European Imbruvica approval for Janssen
July 20, 2015Medical Communications, Sales and Marketing B-cell lymphoma, EC, European Commission, Janssen, Waldenström’s Macroglobulinemia, imbruvica, rare cancer
Janssen has received final European sign-off for its oncology treatment Imbruvica (ibrutinib) as a treatment option for adult patients with …
Ruling in transparency case ‘due within days’
July 17, 2015Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …
Chugai falls foul of ABPI code for close consultant relationship
July 17, 2015Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority
Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …
Novartis receives WHO nod for malaria drug Coartem
July 17, 2015Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization
The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …
AstraZeneca receives US approval for Iressa
July 16, 2015Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer
AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …
It’s time the industry spoke out about legal challenge to clinical trial transparency
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …
Industry awaits outcome of transparency legal challenge
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
UK pharma made £41 million in doctor payments
July 16, 2015Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments
The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …
New Sanofi boss Brandicourt restructures global business
July 16, 2015Sales and Marketing Oliver Brandicourt, Sanofi
Sanofi is reorganising its pharmaceuticals division to create three new business units from January 2016. Chief executive Oliver Brandicourt has …
Janssen sales follow J&J’s downward trend
July 15, 2015Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio
Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …
Celgene to acquire Receptos in $7.2bn deal
July 15, 2015Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis
Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …
MRC, GSK and universities team up on inflammatory diseases
July 15, 2015Research and Development COPD, GSK, MRC, Medical Research Council, fibrosis, inflammatory diseases
UK pharma giant GSK is partnering with the Medical Research Council, to study the biological mechanisms behind common inflammatory diseases. …
Ergomed strengthens management team and board
July 15, 2015Research and Development, Sales and Marketing Andrew Mackie, ergomed
UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …
GSK and the Francis Crick Institute collaborate on drug R&D
July 15, 2015Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research
The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …
Public Health England and Imperial Innovations boost UK life sciences sector
July 14, 2015Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts
The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …
Government launches Accelerated Access Review call to action
July 14, 2015Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister
The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …
FDA approves Lundbeck and Otsuka’s Rexulti for depression
July 14, 2015Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia
Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …
Chancellor announces drug R&D funding boost in Catapult expansion
July 14, 2015Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy
Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …
Allergan closing manufacturing facility in Iceland
July 14, 2015Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies
Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …
Pharma companies look to Apple’s ResearchKit for R&D
July 13, 2015Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit
Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
